Brooks Laboratories Ltd. logo

Brooks Laboratories Ltd. (BROOKS)

Market Closed
7 Aug, 22:00
MSE MSE
60. 85
-0.15
-0.2459%
- Market Cap
- P/E Ratio
- Div Yield
629 Volume
- Eps
61
Previous Close
Add Transaction
Day Range
59.01 62.49
Year Range
36.9 165.95
Want to track BROOKS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BROOKS closed Friday lower at ₹60.85, a decrease of -0.2459% from Thursday's close, completing a monthly decrease of -13.0714% or -₹9.15. Over the past 12 months, BROOKS stock lost -25.693%.
BROOKS is not paying dividends to its shareholders.
The last earnings report, released on May 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.5249%, based on the last three reports.
Brooks Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Feb 11, 2020.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

BROOKS Chart

Brooks Laboratories Ltd. (BROOKS) FAQ

What is the stock price today?

The current price is ₹60.85.

On which exchange is it traded?

Brooks Laboratories Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is BROOKS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Brooks Laboratories Ltd. ever had a stock split?

Brooks Laboratories Ltd. had 1 splits and the recent split was on Feb 11, 2020.

Brooks Laboratories Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Prashant Rathi CEO
MSE Exchange
INE650L01011 ISIN
India Country
293 Employees
- Last Dividend
11 Feb 2020 Last Split
- IPO Date

Overview

Brooks Laboratories Limited is a distinguished player in the pharmaceutical industry, known for its robust manufacturing and distribution capabilities. Established in 2002 and headquartered in Mumbai, India, the company has carved a niche for itself both on domestic and international fronts. Brooks Laboratories Limited specializes in the development, manufacture, and sale of a diverse range of pharmaceutical products, catering to various therapeutic areas and needs. Employing state-of-the-art manufacturing processes and adhering to stringent quality standards, the company ensures that its products are safe, effective, and of high quality. Through its dedication to excellence and innovation, Brooks Laboratories Limited continues to expand its footprint, striving to improve healthcare outcomes globally.

Products and Services

  • Liquid and Dry Powder Injection
  • These products include sterile formulations intended for administration as injections. They cater to various medical conditions, offering both liquid and dry powder forms to suit different therapeutic needs and preferences of administration.

  • Carbapenem Drugs
  • Part of Brooks Laboratories' product lineup includes carbapenem antibiotics, which are used to treat a wide range of serious bacterial infections. These drugs are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

  • Tablets
  • The company produces a variety of tablets designed to address a multitude of health conditions. Tablets are one of the most common pharmaceutical formulations, favored for their ease of consumption, dosage accuracy, and stability.

  • Dry Syrup
  • Dry syrup formulations are provided by Brooks Laboratories, which are essentially powder mixtures requiring reconstitution with water before use. This form is particularly useful for pediatric and geriatric patients who may have difficulty swallowing tablets or capsules.

  • Eye/Ear Drops
  • Comprehensive care for ophthalmic and otic conditions is available through Brooks Laboratories' range of eye and ear drops. These products are formulated to deliver targeted relief and treatment for infections, allergies, and other disorders affecting the eyes and ears.

Contact Information

Address: 201, The Summit Business Bay
Phone: 91 22 6907 3100